{"disease":{"id":"therapeutic-education-program","name":"therapeutic education program"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05320276","title":"Predictors of Non-accESs to therapeutiC EducAtion Programs Among Patients With Type 2 Diabetes, and/or Asthma, and/or Chronic Heart Failure in an Emergency Setting","phase":"","overall_status":"COMPLETED","enrollment_count":297,"lead_sponsor_name":"Fondation Hôpital Saint-Joseph","has_results":false},{"nct_id":"NCT07258810","title":"Evaluation of Tolerance and Quality of Life in Patients With Neuroendocrine Tumors Treated With Oral Anti-Tumor Drugs Within a Therapeutic Education Program","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06478849","title":"Adherence and Understanding of a Therapeutic Education Program for Patients With Central Venous Access (EDUVVC)","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}